4.7 Article

Identification of dihydropyridines that reduce cellular tau levels

Journal

CHEMICAL COMMUNICATIONS
Volume 47, Issue 1, Pages 529-531

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c0cc02253e

Keywords

-

Funding

  1. NIH [GM008353, NS059690, AG031291]
  2. Abe and Irene Pollin CBD Fund
  3. Alzheimer's Association [IRG-09-130689]
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON AGING [K99AG031291, R00AG031291] Funding Source: NIH RePORTER

Ask authors/readers for more resources

A series of dihydropyridines were identified that have an effect on the accumulation of tau, an important target in Alzheimer's disease. The dihydropyridine collection was expanded using the Hantzsch multicomponent reaction to develop preliminary structure-activity relationships.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available